Rapid growth in the monoclonal
antibodies market has been made possible by technological advances in
recombinant monoclonal technologies, showcased by antibody technology experts,
ModiQuest Research, at BIOTECHNICA 2011 (11-13 October, Hannover, Germany). ModiQuest
CEO and President, Dr Jos Raats will be on hand to discuss how their
technologies and specialist reagents have enabled research and development of
new antibody treatments, plus diagnostics, across a range of therapy areas
including autoimmune disease and cancer.
Dr Raats said, "We're looking forward
to meeting researchers in antibody treatments and diagnostics. It is always
mutually beneficial to share knowledge gained with others working in the field
of antibody development. At ModiQuest we develop antibody-related solutions for
even the most intractable targets, so we have a great deal of experience
solving the challenges of this growing area of drug development. There is also
a great deal of interest in our suite of specialist services and products to
support rheumatoid arthritis and other immune disease related research."
Dr Raats will be on hand to discuss
today's challenges of antibody development and production at ModiQuest's
exhibition booth as part of the Netherlands Pavilion in Hall 9, Stand G04.
BIOTECHNICA 2011 is an event which traditionally has four core areas -
biotechnology, lab technology, services and technology transfer. This year
major trends for the future with be examined with three focus themes:
BioServices, Biotechnological Innovation in Food and Industrial Biotechnology.
ModiQuest Research offer an intelligent
approach to antibody generation, cloning, modification and cell line
production. Its offering includes end-to-end support services that include
monoclonal antibody generation, cell line development and antibody production,
plus antibody cloning and sequencing to enable academic, pharmaceutical and
biotechnology clients to develop new and improved antibody treatments and
diagnostics. In addition ModiQuest Research provides a range of immunological
reagents to enable early research into treatments for autoimmune, cancer and
infectious diseases.
For more information about ModiQuest
and to see Dr Raats in action, please click
http://bit.ly/MQR003video or visit
www.modiquestresearch.com
Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!
Request your free copies HERE
Popular this Month
Top 10 most popular articles this month
Today's Picks
Looking for a Supplier?
Search by company or by product
Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.
Lab Bulletin is published by newleaf marketing communications ltd.